Screener
Edwards Lifesciences EW Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Edwards Lifesciences’s 8-K, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:29 PM EDT
- Accession
- 0001099800-26-000038
FAQ
- What is Edwards Lifesciences's other income, net (note 6)?
- Edwards Lifesciences (EW) reported other income, net (note 6) of -$16.6M in Q2 2026.
- How has Edwards Lifesciences's other income, net (note 6) changed year-over-year?
- Edwards Lifesciences's other income, net (note 6) decreased by 1176.9% year-over-year, from -$1.3M to -$16.6M.
- What is the long-term trend for Edwards Lifesciences's other income, net (note 6)?
- Over 4 years (2021 to 2025), Edwards Lifesciences's other income, net (note 6) has grown at a -13.2% compound annual growth rate (CAGR), from $12.7M to $7.2M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Edwards Lifesciences's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude